These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21357720)

  • 1. Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.
    Jehl SP; Doling AM; Giddings KS; Phalipon A; Sansonetti PJ; Goldberg MB; Starnbach MN
    Infect Immun; 2011 May; 79(5):2021-30. PubMed ID: 21357720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity.
    Sellge G; Magalhaes JG; Konradt C; Fritz JH; Salgado-Pabon W; Eberl G; Bandeira A; Di Santo JP; Sansonetti PJ; Phalipon A
    J Immunol; 2010 Feb; 184(4):2076-85. PubMed ID: 20089698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles for T and NK cells in the innate immune response to Shigella flexneri.
    Le-Barillec K; Magalhaes JG; Corcuff E; Thuizat A; Sansonetti PJ; Phalipon A; Di Santo JP
    J Immunol; 2005 Aug; 175(3):1735-40. PubMed ID: 16034114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella impairs T lymphocyte dynamics in vivo.
    Salgado-Pabón W; Celli S; Arena ET; Nothelfer K; Roux P; Sellge G; Frigimelica E; Bousso P; Sansonetti PJ; Phalipon A
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4458-63. PubMed ID: 23417297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.
    Islam D; Bardhan PK; Lindberg AA; Christensson B
    Infect Immun; 1995 Aug; 63(8):2941-9. PubMed ID: 7622216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I.
    Jehl SP; Nogueira CV; Zhang X; Starnbach MN
    PLoS Pathog; 2012; 8(8):e1002809. PubMed ID: 22912573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
    Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
    Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte clones responsive to Shigella flexneri.
    Zwillich SH; Duby AD; Lipsky PE
    J Clin Microbiol; 1989 Mar; 27(3):417-21. PubMed ID: 2654177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.
    Nothelfer K; Arena ET; Pinaud L; Neunlist M; Mozeleski B; Belotserkovsky I; Parsot C; Dinadayala P; Burger-Kentischer A; Raqib R; Sansonetti PJ; Phalipon A
    J Exp Med; 2014 Jun; 211(6):1215-29. PubMed ID: 24863068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a.
    Turbyfill KR; Joseph SW; Oaks EV
    Infect Immun; 1995 Oct; 63(10):3927-35. PubMed ID: 7558301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains.
    Carlin NI; Lindberg AA
    Infect Immun; 1987 Jun; 55(6):1412-20. PubMed ID: 2437036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination With Mouse Dendritic Cells Loaded With an IpaD-IpaB Fusion Provides Protection Against Shigellosis.
    Arizmendi O; Kumar P; Zheng Q; Stewart JP; Picking WD; Picking W; Martinez-Becerra FJ
    Front Immunol; 2019; 10():192. PubMed ID: 30800131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ShiA abrogates the innate T-cell response to Shigella flexneri infection.
    Ingersoll MA; Zychlinsky A
    Infect Immun; 2006 Apr; 74(4):2317-27. PubMed ID: 16552062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
    Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
    PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
    León Y; Zapata L; Salas-Burgos A; Oñate A
    Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate.
    Pore D; Chakrabarti MK
    Vaccine; 2013 Aug; 31(36):3644-50. PubMed ID: 23764536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
    Sagi S; Konduru B; Parida M
    Int Immunopharmacol; 2020 Aug; 85():106617. PubMed ID: 32464569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602.
    Bârzu S; Arondel J; Guillot S; Sansonetti PJ; Phalipon A
    Infect Immun; 1998 Jan; 66(1):77-82. PubMed ID: 9423842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.